Non-comparative Trial Following Participants Implanted Bilaterally With Mini WELL Toric Ready Intraocular Lens for 6 Months After the Second Eye Implant (FUSION)
FUSION
A Multicenter, Non-controlled and Open-label Trial Following Subjects Implanted Bilaterally With the Toric Extended-depth-of-focus Mini WELL Toric Ready Intraocular Lens for 6 Months After the Second Eye Implant
1 other identifier
interventional
58
3 countries
4
Brief Summary
This is a multicenter, non-comparative trial following participants implanted bilaterally with the Mini WELL Toric Ready intraocular lens (IOL) for 6 months after the second eye implant. The objective of the study is to evaluate the clinical performance of the Mini WELL Toric Ready intraocular lens (IOL), in particular, visual performance and rotational stability at 6 months following the second eye implantation in participants suffering from bilateral cataract with corneal astigmatism. There are 2 hypotheses:
- Rotational Stability: the rotation of the Mini WELL Toric Ready IOL compared between Visit 0a (the day of surgery) and Visit 4 (120 180 days post-operative follow-up) shall be less than ±10° in 90% of the cases.
- Severe Visual Distortions: the rate of severe visual distortions for the Mini WELL Toric Ready IOL reported at 6 months postoperative will be less than 10 percents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2019
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 1, 2019
CompletedFirst Posted
Study publicly available on registry
March 4, 2019
CompletedStudy Start
First participant enrolled
September 19, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2021
CompletedApril 18, 2023
April 1, 2023
2.2 years
March 1, 2019
April 14, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Intraocular lens (IOL) rotation
To evaluate the rotational stability of Mini WELL Toric Ready IOL.
6 months after second eye implant
Rate of severe visual distortions
To evaluate the visual performance of Mini WELL Toric Ready IOL.
6 months after second eye implant
Other Outcomes (2)
The rate of visual disturbances as detected with the Halometry test
6 months after second eye implant
The rate of secondary surgical interventions (SSIs) related to the optical properties of the IOL for first and second operative eye separately
6 months after second eye implant
Study Arms (1)
Mini WELL Toric Ready intraocular lens
EXPERIMENTALInterventions
The aim of cataract surgery is to remove the cloudy lens and replace it with the artificial intraocular lens called Mini WELL Toric Ready to correct presbyopia and to correct corneal astigmatism.
Eligibility Criteria
You may qualify if:
- Eighteen years of age or older at the time of surgery and diagnosed with bilateral cataracts;
- Planned bilateral cataract removal by phacoemulsification;
- Preoperative total corneal astigmatism of 0.89 - 2.91 D, measured by corneal topography in both operative eyes;
- IOL power and cylinder requirement calculated by the specific web-based Mini Toric Calculator within the following range:
- Cylinder of: 1.50 D to 4.00 D
- Spherical Equivalent of: 18.00 to 28.00 D
- Willing and able to complete all required postoperative visits;
- Clear intraocular media other than cataract;
- Available for second-eye surgery within 2 weeks of the initial operation;
- Potential postoperative visual acuity of 0.3 logMAR in both eyes;
- Able to comprehend and sign a statement of informed consent consistent with local regulation for research in human subjects.
You may not qualify if:
- Irregular / asymmetric astigmatism;
- Significant irregular corneal aberration as demonstrated by corneal topography;
- Keratopathy / Kerectasia - any corneal abnormality, other than regular corneal astigmatism, including, but not limited to the following: keratoconus, keratoglobus, keratolysis, keratomalacia, keratomicosis and corneal plana;
- Any inflammation or edema (swelling) of the cornea, including but not limited to the following: keratitis, keratoconjuntivitis and keratouveitis;
- Subjects with diagnosed degenerative visual disorder (e.g. macular degeneration or other retinal disorders) that are predicted (by subjective assessment of the retina) to cause future acuity losses to a level worse than 0.3 logMAR;
- Subjects who may have reasonably been expected to require a secondary surgical intervention at any time during the study (other than Nd:YAG capsulotomy);
- Subjects in whom the intraocular lens might interfere with the ability to observe, diagnose or treat posterior segment conditions;
- Previous corneal refractive surgery;
- Other planned ocular surgery procedures, including, but not limited to LASIK, astigmatic keratotomy, retinal laser treatment and limbal relaxing incisions, for the duration of the study;
- Capsular or zonular abnormalities that may affect postoperative centration or tilt of the lens, including but not limited to the following: pseudo-exfoliation syndrome, chronic uveitis, Marfan's Syndrome;
- Absence of adequate capsular support for the implant of the intraocular lens in the capsular bag;
- Absence of adequate support for the lens from the posterior chamber or the zonule;
- Pupil abnormalities, including but not limited to the following: non-reactive, tonic pupils that do not dilatate under mesopic/scotopic conditions, abnormally shaped pupils or abnormally positioned pupils;
- Amblyopia;
- Clinically severe corneal dystrophy (e.g. epithelial, stromal, or endothelial dystrophy);
- +26 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- SIFI SpAlead
Study Sites (4)
Service ophtalmologie Segment Antérieur- Hopital Pellegrin - CHU de Bordeaux
Bordeaux, 33076, France
Universitäts-Augenklinik Heidelberg International Vision Correction Research Centre (IVCRC)
Heidelberg, 69120, Germany
OFTALVIST CIO JEREZ Clínica Jerez (Cadiz)
Jerez de la Frontera, 11407, Spain
Hospital Universitario Quirónsalud Madrid
Madrid, 28223, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 1, 2019
First Posted
March 4, 2019
Study Start
September 19, 2019
Primary Completion
November 30, 2021
Study Completion
November 30, 2021
Last Updated
April 18, 2023
Record last verified: 2023-04